Flow is Life

To become the "1st line on the table therapy" in treating peripheral vascular occlusions by developing a "versatile" solution aimed at rapid reperfusion without the need for surgery or thrombolytic drug therapies.

Learn More

The Future in Treating

Vascular Occlusions

ICHOR’s 7F Percutaneous Reperfusion System

Designed to treat Acute Limb Ischemia (ALI), organized thrombus and other embolic/thrombotic events in the peripheral vasculature

ICHOR’s 7F percutaneous system is designed as a one size fits all system that replicates the parameters of surgical thrombectomy / embolectomy with reduced surgical or drug complications, no blood loss to aspiration, reduced bleeding complications associated with drug therapy, and eliminates the need for general anesthesia. The technology is easily adoptable by interventionalists, incorporates health economics, and specifically designed to make ICHOR a first line therapy for physicians and hospitals.

ICHOR’s 12F Percutaneous Reperfusion System

Designed to treat organized thrombus and other embolic/thrombotic events in the peripheral vasculature

ICHOR’s 12F percutaneous system is designed as a one size fits all system that replicates the parameters of surgical thrombectomy / embolectomy with reduced surgical or drug complications, no blood loss to aspiration, reduced bleeding complications associated with drug therapy, and eliminates the need for general anesthesia. The technology is easily adoptable by interventionalists, incorporates health economics, and specifically designed to make ICHOR a first line therapy for physicians and hospitals.

Advancing Patient Outcomes for Peripheral Artery Disease (PAD): An interview with the Chairman of the Board, Jeff Blair

ICHOR’s Panacea is a much needed technology

...for treating peripheral arterial disease (PAD) in the lower limbs. Current technologies do not deliver the desired therapeutic results, and I believe the Panacea technology can deliver conclusive therapy with a design that is both elegant and intuitive. Lack of reasonable therapies will make Panacea a go-to device”

- Dr. J A Mustapha, FACC, FSCAI, Entrepreneur

tried-and-true balloon technique

ICHOR seeks to bring the vascular occlusions TO the catheter with a tried-and-true balloon technique we are all familiar with. All other technologies are catheters trying to find the occlusion”

- Dr Michael Cohn, Memorial Regional Health System, Hollywood FL

visual1
visual2

Learn how ICHOR can help

Thank you for considering ICHOR Vascular’s treatment of peripheral vascular occlusions. Please submit your e-mail for a copy of our technical brochure.

Disruptive

Safe and effective products to treat vascular occlusions and achieve reperfusion

Innovative

Minimally invasive systems easily adoptable by physicians, hospitals, and office based labs

Improve Outcomes

Reduces or eliminates surgical and drug complications

Better Economics

Technologies aimed at transforming outcomes and the economics in treating vascular occlusions

Find Out More

What Physicians Say

“The ICHOR Panacea device exceeded my expectations in terms of bulk retrieval of organized thrombus, the ease of maneuvering the entire low profile system using rapid exchange technique, and the durability of the device in treating large clot burden.”

Vascular Interventional Radiologist, Tampa, FL

Partner with Us

News

Featured in Vascular Disease Management (VDM): ICHOR & Naglreiter Elevator Incubator Innovating MedTech

Summary: NAGLREITER MedTech Incubator (www.nmddo.com) accelerates time to market with state of the art facilities, business systems, and a proven track record with industry exits and partnerships in partnerships in Neurovascular, Robotics, Cardiovascular, Digital Health, End Effectors, Blades, Scopes, etc.…

Read More

ICHOR Case Study with NAMSA

ICHOR Vascular Featured in Endovascular Today

ICHOR Vascular announces FDA clearance of the ICHOR Reperfusion System 

Read News